Yiwang Guo
Overview
Explore the profile of Yiwang Guo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
26
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guo Y, Martinez L, Palanisamy A, Gururajan B, Sun C
Int J Pharm
. 2024 Oct;
667(Pt A):124855.
PMID: 39442769
Ribbon porosity is a critical parameter to monitor in the roller compaction process. In this study, six techniques for measuring the porosity of solid compacts, i.e., manually by caliper (Caliper),...
2.
Tharanon W, Guo Y, Peerapattana J, Sun C
Int J Pharm
. 2024 Jul;
661:124454.
PMID: 38986964
Powder flow is one of the crucial factors affecting several pharmaceutical manufacturing processes. Problems due to insufficient powder flow reduce production process efficiency and cause suboptimum product quality. The U.S....
3.
Guo Y, Byer-Alcorace A, Thomas C, Piekos S, Luo L, Hawley M, et al.
J Pharm Sci
. 2024 May;
113(8):2506-2512.
PMID: 38768754
In this work, the ability of the artificial stomach and duodenum (ASD) model to predict bioavailability in rats was investigated using a poorly soluble model compound, BI-639667. A solution and...
4.
Wang Z, Wang C, Guo Y, Bahl D, Fok A, Sun C
Int J Pharm
. 2024 Mar;
654:123956.
PMID: 38428547
Tabletability is an outcome of interparticulate bonding area (BA) - bonding strength (BS) interplay, influenced by the mechanical properties, size and shape, surface energetics of the constituent particles, and compaction...
5.
Tsume Y, Ashworth L, Bermejo M, Cheng J, Cicale V, Dressman J, et al.
AAPS J
. 2023 Jun;
25(4):58.
PMID: 37291273
No abstract available.
6.
Paul S, Guo Y, Wang C, Dun J, Sun C
Int J Pharm
. 2023 May;
641:123041.
PMID: 37201765
The development of a high quality tablet of Celecoxib (CEL) is challenged by poor dissolution, poor flowability, and high punch sticking propensity of CEL. In this work, we demonstrate a...
7.
Tsume Y, Ashworth L, Bermejo M, Cheng J, Cicale V, Dressman J, et al.
AAPS J
. 2023 Apr;
25(3):45.
PMID: 37085637
Assessing in vivo performance to inform formulation selection and development decisions is an important aspect of drug development. Biopredictive dissolution methodologies for oral dosage forms have been developed to understand...
8.
Guo Y, Sun C
Int J Pharm
. 2022 Apr;
619:121722.
PMID: 35395363
Using an artificial stomach and duodenum (ASD), we investigated the pH-dependent precipitation of erlotinib (ERL) during dissolution in the gastrointestinal (GI) tract by varying the rate of gastric fluid secretion...
9.
Guo Y, Sun C
Int J Pharm
. 2021 Nov;
611:121310.
PMID: 34822963
The use of the surfactant, sodium lauryl sulfate (SLS), instead of enhancing drug dissolution, deteriorates the dissolution of some alkaline drugs through forming poorly soluble lauryl sulfate salts. The thermodynamic...
10.
Guo Y, Sun C
Mol Pharm
. 2021 Oct;
19(2):432-439.
PMID: 34672628
The anionic surfactant sodium lauryl sulfate (SLS) is known to deteriorate the dissolution of some drugs by forming poorly soluble lauryl sulfate (LS) salts. However, because of the perception of...